Shinde, Vivek; Bhikha, Sutika; Hoosain, Zaheer; Archary, Moherndran; Bhorat, Qasim; Fairlie, Lee; Lalloo, Umesh G.; Mduduzi, S.L.; Masilela, M.B.; Moodley, Dhayendre; Hanley, Sherika; Fouche, Leon; Louw, Cheryl; Tameris, Michele; Singh, Nishanta; Goga, Ameena Ebrahim; Dheda, Keertan; Kruger, Gertruida; Carrim‑Ganey, Nazira; Baillie, Vicky; De Oliveira, Tulio; Koen, Anthonet Lombard; Lombaard, Johan J.; Mngqibisa, Rosie; Bhorat, As’ad E.; Benade, Gabriella; Lalloo, Natasha; Pitsi, Annah; Vollgraaff, Pieter‑Louis; Luabeya, Angelique; Esmail, Aliasgar; Petrick, Friedrich G.; Oommen‑Jose, Aylin; Foulkes, Sharne; Ahmed, Khatija; Thombrayil, Asha; Fries, Lou; Cloney‑Clark, Shane; Zhu, Mingzhu; Bennett, Chijioke; Albert, Gary; Faust, Emmanuel; Plested, Joyce S.; Robertson, Andreana; Neal, Susan; Cho, Iksung; Glenn, Greg M.; Dubovsky, Filip; Madhi, Shabir A.
(Massachusetts Medical Society, 2021-05-05)
BACKGROUND : The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) pandemic. In a phase 1–2 trial involving ...
